期刊文献+

丁香柿楴汤合洛贝林治疗顽固性呃逆的临床观察 被引量:6

Effect of Dingxiang persimmon stem decoction combined with lobeline on intractable hiccup
下载PDF
导出
摘要 目的观察丁香柿楴汤合并洛贝林治疗顽固性呃逆临床疗效和不良反应。方法选自60例顽固性呃逆患者,根据就诊先后随机分为研究组(丁香柿楴汤合洛贝林)和对照组(洛贝林)各30例。对照组给予洛贝林3 mg肌注,1次/天,研究组加服丁香柿楴汤。对两组病例治疗前后有效率、起效时间及病程分别进行对比观察。结果在起效时间方面,研究组优于对照组,差异有统计学意义(P<0.05)。在疗程方面,研究组疗程较对照组明显缩短,差异有统计学意义(P<0.05)。在有效率方面,研究组24 h、48 h、72 h、96 h有效率分别为76.7%、90.0%、100.0%、100.0%;对照组24 h、48 h、72 h、96 h有效率分别为53.3%、70%、80%、83.3%,研究组有效率优于对照组(P<0.05)。结论丁香柿楴汤合洛贝林治疗顽固性呃逆临床疗效是可靠的,未发现明显不良反应,值得临床推广。 Objective To observe the effect and adverse reactions of Dingxiang persimmon stem decoction combined with lobeline on intractable hiccup.Methods Sixty patients with intractable hiccup were randomly divided into experimental group (Dingxiang persimmon stem decoction combined with lobeline)and control group (lobeline), patients in each group.The control group was given 3 mg lobeline intramuscular injection,once a day.Patients in experi-mental group were given lobelinec ombined with Dingxiang persimmon stem decoction.The efficiency,onset time and course of disease were compared between the two groups before and after treatment.Results The onset time and dura-tion of experimental group were shorter than those in the control group,there were significant differences between the two groups (P 〈0.05).The effective rates of experimental group at 24,72,48,96 hours were 76.7%,90.0%,100.0%, 100.0% respectively;and the rates of control group were 53.3%,70.0%,80.0%,83.33% respectively,the experi-mental group was more efficient than the control group (P 〈0.05).Conclusion Dingxiang persimmon stem decoction combined with lobeline is effective in the treatment of intractable hiccup without obvious side effects.
出处 《中国临床保健杂志》 CAS 2016年第4期383-385,共3页 Chinese Journal of Clinical Healthcare
基金 安徽医科大学2014年新技术新项目
关键词 呃逆 丁香柿蒂汤 洛贝林 Hiccup Dingxiang shidi decoction Lobeline
  • 相关文献

参考文献12

二级参考文献50

  • 1陈英.电针加穴位注射治疗脑血管病引起顽固性呃逆80例[J].四川中医,2006,24(9):96-97. 被引量:5
  • 2Schaich M,Soucek S,Thiede C,et al.MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia[J].Br J Haematol,2005,128(3):324-332.
  • 3Marzolini C,Paus E,Buclin T,et al.Polymorphisms in human MDR1 (P-glycoprotein):recent advances and clinical relevance[J].Clin Pharmacol Ther,2004,75(1):13-33.
  • 4Anthony V,Skach W R.Molecular mechanism of P-glycoprotein assembly into cellular membranes[J].Curr Protein Pept Sci,2002,3(5):485-501.
  • 5Lin J H,Yamazaki M.Clinical relevance of P-glycoprotein in drug therapy[J].Drug Metab Rev,2003,35(4):417-454.
  • 6Ma Y,Wink M.Lobeline,a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells[J].Phytomedicine,2008,15(9):754-758.
  • 7Gottesman M M,Ling V.The molecular basis of multidrug resistance in cancer:the early years of P-glycoprotein research[J].FEBS Lett,2006,580(4):998-1009.
  • 8Glavinas H,Krajcsi P,Cserepes J,et al.The role of ABC transporters in drug resistance,metabolism and toxicity[J].Curr Drug Deliv,2004,1(1):27-42.
  • 9Lehne G.P-glycoprotein as a drug target in the treatment of multidrug resistant cancer[J].Curr Drug Targets,2000,1(1):85-99.
  • 10Troutman M D,Thakker D R.Rhodamine123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cell[J].Pharm Res,2003,20(3):1192-1199.

共引文献84

同被引文献43

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部